ACAD
42.22
+4.15
+10.90%
AEMD
7.67
-0.18
-2.29%
APRI
1.62
-0.07
-4.1361%
ARNA
2.78
+0.08
+2.96%
ATEC
0.588
+0.018
+3.158%
CNAT
3.99
+0.02
+0.50%
CRXM
0.35
0.00
0.00%
CYTX
0.365
+0.012
+3.3682%
DXCM
89.02
-0.35
-0.39%
GNMK
9.73
-0.08
-0.82%
HALO
17.77
+0.23
+1.31%
ILMN
197.89
-0.22
-0.11%
INNV
0.11
0.00
+0.09%
INO
7.22
-0.01
-0.14%
ISCO
3.6
-0.1
-2.70%
ISIS
52.13
+0.38
+0.73%
LGND
91.21
-1.21
-1.31%
LPTN
0.24
-0.001
-0.5797%
MBVX
1.52
-0.16
-9.79%
MEIP
1.901
+0.041
+2.204%
MNOV
3.27
+0.13
+4.14%
MRTX
27
-0.84
-3.02%
MSTX
0.49
+0.01
+2.92%
NBIX
50.07
+0.44
+0.8864%
NUVA
52.38
+0.23
+0.44%
ONCS
5.65
-0.11
-1.91%
ONVO
2.78
+0.14
+5.30%
OREX
2.815
+0.07
+2.550%
OTIC
22.01
-0.38
-1.70%
QDEL
21.185
-0.265
-1.235%
RCPT
231.96
0.00
0.00%
RGLS
9.13
-0.11
-1.19%
RMD
51.98
+0.07
+0.13%
SCIE
0.014
0.00
0.00%
SPHS
0.843
-0.007
-0.824%
SRNE
13.08
-0.24
-1.80%
TROV
6.12
-0.21
-3.32%
VICL
0.61
+0.01
+1.58%
VOLC
18
0.00
0.00%
ZGNX
20.34
-0.16
-0.78%
ACAD
42.22
+4.15
+10.90%
AEMD
7.67
-0.18
-2.29%
APRI
1.62
-0.07
-4.1361%
ARNA
2.78
+0.08
+2.96%
ATEC
0.588
+0.018
+3.158%
CNAT
3.99
+0.02
+0.50%
CRXM
0.35
0.00
0.00%
CYTX
0.365
+0.012
+3.3682%
DXCM
89.02
-0.35
-0.39%
GNMK
9.73
-0.08
-0.82%
HALO
17.77
+0.23
+1.31%
ILMN
197.89
-0.22
-0.11%
INNV
0.11
0.00
+0.09%
INO
7.22
-0.01
-0.14%
ISCO
3.6
-0.1
-2.70%
ISIS
52.13
+0.38
+0.73%
LGND
91.21
-1.21
-1.31%
LPTN
0.24
-0.001
-0.5797%
MBVX
1.52
-0.16
-9.79%
MEIP
1.901
+0.041
+2.204%
MNOV
3.27
+0.13
+4.14%
MRTX
27
-0.84
-3.02%
MSTX
0.49
+0.01
+2.92%
NBIX
50.07
+0.44
+0.8864%
NUVA
52.38
+0.23
+0.44%
ONCS
5.65
-0.11
-1.91%
ONVO
2.78
+0.14
+5.30%
OREX
2.815
+0.07
+2.550%
OTIC
22.01
-0.38
-1.70%
QDEL
21.185
-0.265
-1.235%
RCPT
231.96
0.00
0.00%
RGLS
9.13
-0.11
-1.19%
RMD
51.98
+0.07
+0.13%
SCIE
0.014
0.00
0.00%
SPHS
0.843
-0.007
-0.824%
SRNE
13.08
-0.24
-1.80%
TROV
6.12
-0.21
-3.32%
VICL
0.61
+0.01
+1.58%
VOLC
18
0.00
0.00%
ZGNX
20.34
-0.16
-0.78%

Headline »

July 5, 2015 – 1:13 pm

The San Diego Biotechnology Network will be seven years old this October, can you believe it? We got a nice makeover thanks to Brianne Grajkowski recently in anticipation of our Founder Mary Canady’s presentation at …

Read the full story »

Breaking San Diego Biotech News

Neurocrine Biosciences Announces The Appointment Of To Its Board Of Directors

September 2, 2015 – 5:00 pm

SAN DIEGO, Sept. 3, 2015 /PRNewswire/ –Neurocrine Biosciences, Inc. (NASDAQ: NBIX) announced today that it has appointed Alfred W. Sandrock, Jr., M.D., Ph.D. to its Board of Directors effective immediately. Dr. Sandrock is the current Group Senior Vic…

Topol Calls on Healthcare Industry to “Emancipate” Patient Data

September 2, 2015 – 1:11 pm

Eric Topol has a long list of job titles. From a talk yesterday in San Diego, he might be aiming to add a new moniker, as “the great emancipator” of electronic medical records. Already a…

[[Click headline to continue reading.]]

NuVasive to Participate in Investor Events in September 2015

September 2, 2015 – 1:05 pm

SAN DIEGO, CA–(Marketwired – September 02, 2015) – NuVasive, Inc. ( NASDAQ : NUVA ), a leading medical device company focused on transforming spine surgery with minimally disruptive, procedurally-integrated solutions, announced today that management w…

UC San Diego Health to Manage Emergency Services at El Centro Regional Medical Center

September 2, 2015 – 10:40 am

From comprehensive stroke care when every second counts to stitching deep cuts and evaluating flu symptoms, UC San Diego Health provides the highest quality of care when patients arrive through the emergency room doors. Now, as part of a long term part…


See All News>>

Newest San Diego Biotech Jobs

Director, Evidence Sciences

Hiring Company: Doctor Evidence
Location: Santa Monica, CA
Description: Company:
Headquartered in Santa Monica, CA, Doctor Evidence is a comprehensive evidence-based medicine software platform solution that enables users to conduct comprehensive evidence-based medicine reviews to enable the transformation …

Technical Product Manager

Hiring Company: Invivoscribe
Job Code: TPM
Location: San Diego
Description: Reports To:
Senior Marketing Manager
Department:
Sales and Marketing
Basic Function and Scope of the Position:
Lead the product management of Invivoscribe’s reagent portfolio both tactically and strategically to support the …

Purchasing Coordinator / Buyer (La Jolla)

A growing company within the Life Sciences/Bio-Tech industry is seeking a Purchasing Coordinator/Jr Buyer to join their growing team in the Sorrento Valley/Mira Mesa area of San Diego. This role will be responsible for purchasing a large variety of i […

Portfolio & Operations Coordinator, Oncology Research Unit (ORU) – Pfizer Inc. – La Jolla, CA

Experience in a biotechnology or pharmaceutical company highly preferred. Org Marketing Statement….
From Pfizer Inc. – 03 Sep 2015 10:10:22 GMT
– View all La Jolla jobs


See All Jobs>>

San Diego Biotech Blog Feed

Trilink: RNA Vaccines: Safer and Better Than Pathogens

Polio Virus Accidentally Discharged by GlaxoSmithKline   Anthrax Accidentally Shipped to Numerous Labs New RNA Vaccines are Viewed as Much Safer and Better Polio Virus Accidental Discharge The genesis of this blog about safer, better vaccines using RNA instead of … Continue reading → The... More...

Birch Aquarium: All in the Aquarium Family

By Caitlin Scully Birch Aquarium has a way of making employees feel like family. The common thread of being passionate about ocean science often builds lasting relationships between staff members and with Scripps Institution of Oceanography. There are people who have worked or volunteered at Birch... More...

Neuwrite SD: Two brains in one head?: The story of the split-brain phenomenon

The idea that a person is right-brained or left-brained is a myth However, the brain is indeed split into a right and left hemisphere, and the two are connected by a structure called the “corpus callosum”, a bundle of nerves through which information can be shared.... More...

Su Lab: Three doc sets down!

Last week, Mark2Curators completed the FBX-Engase doc set which was roughly 30% the size of the Alacrima doc set. Forty-five... More...